Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
Condition(s):Dermatomyositis; PolymyositisLast Updated:September 1, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Dermatomyositis; PolymyositisLast Updated:September 1, 2017Completed
Condition(s):Rheumatoid ArthritisLast Updated:September 6, 2023Completed
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:September 16, 2021Completed
Condition(s):ScleritisLast Updated:October 23, 2023Recruiting
Condition(s):Multiple Sclerosis (MS)Last Updated:September 16, 2014Completed
Condition(s):Fibrillary GlomerulonephritisLast Updated:October 31, 2022Active, not recruiting
Condition(s):Steroid-Resistant Nephrotic SyndromeLast Updated:April 23, 2019Withdrawn
Condition(s):Multiple SclerosisLast Updated:September 6, 2017Unknown status
Condition(s):Treatment Resistant Nephrotic SyndromeLast Updated:April 24, 2014Completed
Condition(s):Sarcoidosis, PulmonaryLast Updated:February 27, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.